Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Gains from Investment Securities (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Gains from Investment Securities for 6 consecutive years, with -$4.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 157.8% year-over-year to -$4.4 million, compared with a TTM value of -$415000.0 through Dec 2025, down 654.55%, and an annual FY2025 reading of -$415000.0, down 654.55% over the prior year.
  • Gains from Investment Securities was -$4.4 million for Q4 2025 at Cytek Biosciences, down from $4.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.9 million in Q3 2021 and bottomed at -$4.4 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $970665.2, with a median of $125000.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities surged 1914.57% in 2021, then crashed 198.88% in 2023.
  • Year by year, Gains from Investment Securities stood at -$2.2 million in 2021, then skyrocketed by 130.86% to $690751.0 in 2022, then plummeted by 198.88% to -$683000.0 in 2023, then plummeted by 147.73% to -$1.7 million in 2024, then crashed by 157.8% to -$4.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CTKB at -$4.4 million in Q4 2025, $4.2 million in Q3 2025, and $1.2 million in Q2 2025.